Capricor Therapeutics logo

Capricor Therapeutics Share Price Today

(NASDAQ: CAPR)

Capricor Therapeutics share price is $12.65 & ₹1,100.16 as on 6 Mar 2025, 2.30 'hrs' IST

$12.65

▲

-1.05

(-7.66%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Capricor Therapeutics share price in Dollar and Rupees. Guide to invest in Capricor Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Capricor Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Capricor Therapeutics share price movements

  • Today's Low: $12.08
    Today's High: $13.89

    Day's Volatility :13.0%

  • 52 Weeks Low: $3.52
    52 Weeks High: $23.40

    52 Weeks Volatility :84.96%

Capricor Therapeutics (CAPR) Returns

PeriodCapricor Therapeutics IncIndex (Russel 2000)
3 Months
-5.71%
0.0%
6 Months
223.11%
0.0%
1 Year
164.22%
0.0%
3 Years
205.12%
-11.6%

Capricor Therapeutics (CAPR) Key Statistics

in dollars & INR

Previous Close
$13.7
Open
$13.9
Today's High
$13.885
Today's Low
$12.08
Market Capitalization
$621.6M
Today's Volume
$585.1K
52 Week High
$23.4
52 Week Low
$3.52
Revenue TTM
$23.2M
EBITDA
$-34.8M
Earnings Per Share (EPS)
$-1.02
Profit Margin
-146.86%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-102.63%

How to invest in Capricor Therapeutics Stock (CAPR) from India?

It is very easy for Indian residents to invest directly in Capricor Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Capricor Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Capricor Therapeutics or CAPR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Capricor Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Capricor Therapeutics shares which would translate to 0.069 fractional shares of Capricor Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Capricor Therapeutics, in just a few clicks!

Returns in Capricor Therapeutics (CAPR) for Indian investors in Rupees

The Capricor Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Capricor Therapeutics investment value today

Current value as on today

₹2,48,701

Returns

₹1,48,701

(+148.7%)

Returns from Capricor Therapeutics Stock

₹1,43,738 (+143.74%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Capricor Therapeutics (CAPR)

45%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Capricor Therapeutics Stock from India on INDmoney has increased by 45% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Capricor Therapeutics

  • BlackRock Inc

    6.53%

  • Vanguard Group Inc

    5.01%

  • Farallon Capital Management, L.L.C.

    4.95%

  • State Street Corp

    4.86%

  • Geode Capital Management, LLC

    1.93%

  • Altium Capital Management, LP

    1.57%

Analyst Recommendation on Capricor Therapeutics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Capricor Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Capricor Therapeutics Stock (CAPR)

What analysts predicted

Upside of 226.37%

Target:

$41.29

Current:

$12.65

Insights on Capricor Therapeutics Stock (Ticker Symbol: CAPR)

  • Price Movement

    In the last 6 months, CAPR stock has moved up by 223.1%

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 12.08M → 2.26M (in $), with an average decrease of 40.5% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -762.08K → -12.55M (in $), with an average decrease of 403.9% per quarter

CAPR Capricor Therapeutics Financials in INR & Dollars

FY18Y/Y Change
Revenue
$1.7M
↑ 22.25%
Net Income
$-15.2M
↓ 724.78%
Net Profit Margin
-908.91%
↓ 1086.75%
FY19Y/Y Change
Revenue
$1.0M
↓ 39.87%
Net Income
$-7.4M
↓ 51.43%
Net Profit Margin
-734.09%
↑ 174.82%
FY20Y/Y Change
Revenue
$310.3K
↓ 69.13%
Net Income
$-13.5M
↑ 82.71%
Net Profit Margin
-4.3K%
↓ 3610.86%
FY21Y/Y Change
Revenue
$244.9K
↓ 21.06%
Net Income
$-19.4M
↑ 43.98%
Net Profit Margin
-7.9K%
↓ 3580.43%
FY22Y/Y Change
Revenue
$2.5M
↑ 940.81%
Net Income
$-29.0M
↑ 49.51%
Net Profit Margin
-1.1K%
↑ 6786.9%
FY23Y/Y Change
Revenue
$25.2M
↑ 887.79%
Net Income
$-22.3M
↓ 23.2%
Net Profit Margin
-88.52%
↑ 1049.96%
Q2 FY23Q/Q Change
Revenue
$3.9M
↑ 31.16%
Net Income
$-7.4M
↓ 101.8%
Net Profit Margin
-188.04%
↓ 13871.18%
Q3 FY23Q/Q Change
Revenue
$6.2M
↑ 57.9%
Net Income
$-6.4M
↓ 13.25%
Net Profit Margin
-103.31%
↑ 84.73%
Q4 FY23Q/Q Change
Revenue
$12.1M
↑ 95.42%
Net Income
$-762.1K
↓ 88.07%
Net Profit Margin
-6.3%
↑ 97.01%
Q1 FY24Q/Q Change
Revenue
$4.9M
↓ 59.41%
Net Income
$-9.8M
↑ 1185.16%
Net Profit Margin
-199.6%
↓ 193.3%
Q2 FY24Q/Q Change
Revenue
$4.0M
↓ 19.06%
Net Income
$-11.0M
↑ 12.31%
Net Profit Margin
-276.97%
↓ 77.37%
Q3 FY24Q/Q Change
Revenue
$2.3M
↓ 43.05%
Net Income
$-12.6M
↑ 14.15%
Net Profit Margin
-555.2%
↓ 278.23%
FY18Y/Y Change
Profit
$1.7M
↑ 22.25%
FY19Y/Y Change
Profit
$-4.1M
↓ 347.51%
FY20Y/Y Change
Profit
$-8.1M
↑ 96.93%
FY21Y/Y Change
Profit
$-799.0
↓ 99.99%
FY22Y/Y Change
Profit
$1.9M
↓ 232145.81%
FY23Y/Y Change
Profit
$24.1M
↑ 1200.36%
Q2 FY23Q/Q Change
Profit
$3.7M
↓ 178.49%
Q3 FY23Q/Q Change
Profit
$5.9M
↑ 61.05%
Q4 FY23Q/Q Change
Profit
$11.8M
↑ 99.35%
Q1 FY24Q/Q Change
Profit
$4.6M
↓ 61.16%
Q2 FY24Q/Q Change
Profit
$3.6M
↓ 21.0%
Q3 FY24Q/Q Change
Profit
$2.3M
↓ 37.43%
FY18Y/Y Change
Operating Cash Flow
$-13.9M
↓ 2.59%
Investing Cash Flow
$4.7M
↓ 6.22%
Financing Cash Flow
$6.9M
↓ 40.82%
FY19Y/Y Change
Operating Cash Flow
$-6.8M
↓ 50.79%
Investing Cash Flow
$-3.0M
↓ 164.26%
Financing Cash Flow
$9.2M
↑ 33.91%
FY20Y/Y Change
Operating Cash Flow
$-10.1M
↑ 47.4%
Investing Cash Flow
$5.4M
↓ 281.18%
Financing Cash Flow
$33.4M
↑ 263.73%
FY21Y/Y Change
Operating Cash Flow
$-16.8M
↑ 67.18%
Investing Cash Flow
$-1.2M
↓ 121.99%
Financing Cash Flow
$20.2M
↓ 39.41%
FY22Y/Y Change
Operating Cash Flow
$4.9M
↓ 129.25%
Investing Cash Flow
$-35.1M
↑ 2831.78%
Financing Cash Flow
$4.9M
↓ 75.9%
Q2 FY23Q/Q Change
Operating Cash Flow
$-9.4M
↓ 323.69%
Investing Cash Flow
$6.5M
↓ 301.18%
Financing Cash Flow
$2.2M
↑ 56076.48%

Capricor Therapeutics Technicals Summary

Sell

Neutral

Buy

Capricor Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Capricor Therapeutics (CAPR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Capricor Therapeutics Inc logo
Capricor Therapeutics Inc
-9.09%
223.11%
164.22%
205.12%
1344.54%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
Beone Medicines Ltd
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Capricor Therapeutics Inc logo
Capricor Therapeutics Inc
NA
NA
0.0
-1.0
-1.03
-0.35
NA
1.69
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Capricor Therapeutics Inc logo
Capricor Therapeutics Inc
Buy
$621.6M
1344.54%
NA
-146.86%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
Buy
$31.5B
120.93%
NA
-12.37%

About Capricor Therapeutics

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase 3 clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD). It also focused on developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases. In addition, the company develops CAP-2003, under pre-clinical development for the treatment of trauma related injuries and conditions. It has collaboration and distribution agreement with Nippon Shinyaku Co. Ltd., collaboration agreement with National Institute of Allergy and Infectious Diseases, license agreements with the Johns Hopkins University and Cedars-Sinai Medical Center, as well as cell line license agreement with Life Technologies Corporation. The company was founded in 2005 and is headquartered in San Diego, California.
Organization
Capricor Therapeutics
Employees
101
CEO
Dr. Linda Marbán Ph.D.
Industry
Health Technology

Management People of Capricor Therapeutics

NameTitle
Dr. Frank Isaac Litvack FACC, M.D.
Executive Chairman of the Board
Dr. Linda Marbán Ph.D.
Co-Founder, President, CEO & Director
Mr. Anthony J. Bergmann M.B.A.
CFO & Corporate Treasurer
Ms. Karen G. Krasney Esq., J.D.
Executive VP, General Counsel & Secretary
Dr. Kristi A. H. Elliott Ph.D.
Chief Science Officer
Mr. Minghao Sun Ph.D.
Senior VP of Research & Product Development
Mr. Mark Awadalla
Chief Development Officer
Catherine Lee Kelleher
Consultant

Important FAQs about investing in CAPR Stock from India :

What is Capricor Therapeutics share price today?

Capricor Therapeutics share price today stands at $12.65, Open: $13.90 ; Previous Close: $13.70 ; High: $13.89 ; Low: $12.08 ; 52 Week High: $23.40 ; 52 Week Low: $3.52.

The stock opens at $13.90, after a previous close of $13.70. The stock reached a daily high of $13.89 and a low of $12.08, with a 52-week high of $23.40 and a 52-week low of $3.52.

Can Indians buy Capricor Therapeutics shares?

Yes, Indians can invest in the Capricor Therapeutics (CAPR) from India.

With INDmoney, you can buy Capricor Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Capricor Therapeutics at zero transaction cost.

How can I buy Capricor Therapeutics shares from India?

It is very easy to buy Capricor Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Capricor Therapeutics (CAPR) be purchased?

Yes, you can buy fractional shares of Capricor Therapeutics with INDmoney app.

What are the documents required to start investing in Capricor Therapeutics stocks?

To start investing in Capricor Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Capricor Therapeutics Stock (CAPR)?

Today’s highest price of Capricor Therapeutics (CAPR) is $13.89.

Today’s lowest price of Capricor Therapeutics (CAPR) is $12.08.

What is today's market capitalisation of Capricor Therapeutics?

Today's market capitalisation of Capricor Therapeutics CAPR is 621.6M

What is the 52 Week High and Low Range of Capricor Therapeutics Stock (CAPR)?

  • 52 Week High

    $23.40

  • 52 Week Low

    $3.52

What are the historical returns of Capricor Therapeutics (CAPR)?

  • 1 Month Returns

    -9.09%

  • 3 Months Returns

    223.11%

  • 1 Year Returns

    164.22%

  • 5 Years Returns

    1344.54%

Who is the Chief Executive Officer (CEO) of Capricor Therapeutics ?

Dr. Linda Marbán Ph.D. is the current Chief Executive Officer (CEO) of Capricor Therapeutics.